Cargando…

A novel prognostic time window based on conditional survival and outcomes analyses of primary liver cancer patients

BACKGROUND: Liver cancer is one of the most deadly and prevalent cancers. A routine follow‐up plan for liver cancer is crucial but limited. In the present study, we aimed to disclose possible risk factors and critical survival time windows for primary liver cancer. METHODS: We enrolled 692 liver can...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Weicheng, Hong, Weifeng, Qiu, Haibo, Zhou, Zhongguo, He, Zhonglian, Zeng, Weian, Zhong, Weiqiang, Xie, Jingdun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582677/
https://www.ncbi.nlm.nih.gov/pubmed/35460212
http://dx.doi.org/10.1002/cam4.4762
_version_ 1784812895624757248
author Lu, Weicheng
Hong, Weifeng
Qiu, Haibo
Zhou, Zhongguo
He, Zhonglian
Zeng, Weian
Zhong, Weiqiang
Xie, Jingdun
author_facet Lu, Weicheng
Hong, Weifeng
Qiu, Haibo
Zhou, Zhongguo
He, Zhonglian
Zeng, Weian
Zhong, Weiqiang
Xie, Jingdun
author_sort Lu, Weicheng
collection PubMed
description BACKGROUND: Liver cancer is one of the most deadly and prevalent cancers. A routine follow‐up plan for liver cancer is crucial but limited. In the present study, we aimed to disclose possible risk factors and critical survival time windows for primary liver cancer. METHODS: We enrolled 692 liver cancer patients from Sun Yat‐sen University Cancer Center (SYSUCC). Univariate and multivariate logistic regression analyses of cirrhosis and recurrence were conducted. A meta‐analysis was utilized to validate an indication of creatinine (CRE) in recurrence. Conditional survival analysis was performed using the Kaplan–Meier method. The results were further verified by the SYSUCC validation cohort and Surveillance, Epidemiology, and End Results (SEER) validation cohort. RESULTS: Our results indicated that A/G, history of hepatitis, history of alcohol consumption and platelet (PLT) might be potential prognostic factors for cirrhosis in liver cancer patients. CRE was significantly correlated with recurrence due to various therapies, especially after transarterial embolization. Moreover, 1.5 years to 2 years may be a critical time window for deterioration in survival rate based on the conditional survival analysis. CONCLUSION: A/G, history of hepatitis, alcohol consumption and PLT may be potential prognostic factors for cirrhosis in liver cancer patients. More attention should be focused on the renal function when treating the patients due to the significant role of CRE. 1.5 years to 2 years is a critical time window for deterioration in survival rate for liver cancer patients that contributes to determining the optimal follow‐up plan in the future.
format Online
Article
Text
id pubmed-9582677
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95826772022-10-21 A novel prognostic time window based on conditional survival and outcomes analyses of primary liver cancer patients Lu, Weicheng Hong, Weifeng Qiu, Haibo Zhou, Zhongguo He, Zhonglian Zeng, Weian Zhong, Weiqiang Xie, Jingdun Cancer Med RESEARCH ARTICLES BACKGROUND: Liver cancer is one of the most deadly and prevalent cancers. A routine follow‐up plan for liver cancer is crucial but limited. In the present study, we aimed to disclose possible risk factors and critical survival time windows for primary liver cancer. METHODS: We enrolled 692 liver cancer patients from Sun Yat‐sen University Cancer Center (SYSUCC). Univariate and multivariate logistic regression analyses of cirrhosis and recurrence were conducted. A meta‐analysis was utilized to validate an indication of creatinine (CRE) in recurrence. Conditional survival analysis was performed using the Kaplan–Meier method. The results were further verified by the SYSUCC validation cohort and Surveillance, Epidemiology, and End Results (SEER) validation cohort. RESULTS: Our results indicated that A/G, history of hepatitis, history of alcohol consumption and platelet (PLT) might be potential prognostic factors for cirrhosis in liver cancer patients. CRE was significantly correlated with recurrence due to various therapies, especially after transarterial embolization. Moreover, 1.5 years to 2 years may be a critical time window for deterioration in survival rate based on the conditional survival analysis. CONCLUSION: A/G, history of hepatitis, alcohol consumption and PLT may be potential prognostic factors for cirrhosis in liver cancer patients. More attention should be focused on the renal function when treating the patients due to the significant role of CRE. 1.5 years to 2 years is a critical time window for deterioration in survival rate for liver cancer patients that contributes to determining the optimal follow‐up plan in the future. John Wiley and Sons Inc. 2022-04-22 /pmc/articles/PMC9582677/ /pubmed/35460212 http://dx.doi.org/10.1002/cam4.4762 Text en © 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle RESEARCH ARTICLES
Lu, Weicheng
Hong, Weifeng
Qiu, Haibo
Zhou, Zhongguo
He, Zhonglian
Zeng, Weian
Zhong, Weiqiang
Xie, Jingdun
A novel prognostic time window based on conditional survival and outcomes analyses of primary liver cancer patients
title A novel prognostic time window based on conditional survival and outcomes analyses of primary liver cancer patients
title_full A novel prognostic time window based on conditional survival and outcomes analyses of primary liver cancer patients
title_fullStr A novel prognostic time window based on conditional survival and outcomes analyses of primary liver cancer patients
title_full_unstemmed A novel prognostic time window based on conditional survival and outcomes analyses of primary liver cancer patients
title_short A novel prognostic time window based on conditional survival and outcomes analyses of primary liver cancer patients
title_sort novel prognostic time window based on conditional survival and outcomes analyses of primary liver cancer patients
topic RESEARCH ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582677/
https://www.ncbi.nlm.nih.gov/pubmed/35460212
http://dx.doi.org/10.1002/cam4.4762
work_keys_str_mv AT luweicheng anovelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients
AT hongweifeng anovelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients
AT qiuhaibo anovelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients
AT zhouzhongguo anovelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients
AT hezhonglian anovelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients
AT zengweian anovelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients
AT zhongweiqiang anovelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients
AT xiejingdun anovelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients
AT luweicheng novelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients
AT hongweifeng novelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients
AT qiuhaibo novelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients
AT zhouzhongguo novelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients
AT hezhonglian novelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients
AT zengweian novelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients
AT zhongweiqiang novelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients
AT xiejingdun novelprognostictimewindowbasedonconditionalsurvivalandoutcomesanalysesofprimarylivercancerpatients